Apr 14, 2011 - 3:50 pm
The updated NCCN (National Comprehensive Cancer Network) guidelines “…urge clinicians to offer active surveillance to their patients whose prostate cancers are at low risk of progressing to life-threatening disease”.
The Guidelines added a new category in the classification of patients as “very-low risk or clinically insignificant prostate cancer”. Patients with a life expectancy of up to 20 years and that fall into the very-low risk category, the guidelines recommend physicians to advise only active surveillance as the preferred management approach”.
The parameters for AS includes the majority of newly diagnosed patients in present days due to earlier prevention protocols. These are the required status:
I would recommend to the many to read this article.